Date: June 23, 2021
Time: 9:00am PDT, 12:00pm EDT
Adeno-associated virus (AAV) is rapidly becoming the go-to biological delivery method for the latest gene therapy breakthroughs. AAV has an efficacy and safety profile that makes it an ideal therapeutic vector—already part of several high-profile drug approvals in both the US and Europe. Yet, with this intensified interest in AAV therapies comes the need to scale-up viral production methods. As such, it’s imperative that successful viral production produce high titers that is cost-effective and scalable. During this webinar session, our presenter will highlight a scalable, high-titer, simplified AAV production in the AAV-MAX helper free AAV Production System.
- Awareness of the Gibco AAV-MAX Helper-Free AAV Production System that is in the market and the upcoming launch of the RUO version
- Learn how to produce high titers with the Gibco AAV production system that allows for cost-effective scalability for AAV production.
Webinars will be available for unlimited on-demand viewing after live event.